Insights from the 2026 ISPE Annual Meeting & Expo Chairs

Published September 2026

 Listen to Audio

Audio file

In this episode, the Executive Chair of the 2026 ISPE Annual Meeting and Expo, Jose Caraballo Oramas, and the International Program Committee Chair, Connie Langer, join the podcast to preview the upcoming conference in Washington, D.C. They explore the featured topics, trends, and key highlights of what attendees can expect from the educational content and agenda.

Learn about the five interconnected educational tracks, which delve into topics like how pharmaceutical operations can balance advanced digital innovations, such as artificial intelligence, with robust governance and human accountability, and how modern systems and workforce upskilling contribute to reliable, patient-centric drug manufacturing.


What Can Attendees Expect at the 2026 ISPE Annual Meeting & Expo?

In this episode of the ISPE Podcast: Shaping the Future of Pharma, Jose Caraballo-Oramas, Founder and Principal, JCO Global Advisory LLC, and Connie Langer, Regulatory Intelligence Lead, Pharma Quality, Safety and Environmental Operations, Pfizer Global Supply, provide a preview of the 2026 ISPE Annual Meeting & Expo and discuss the trends, challenges, and opportunities shaping the future of the pharmaceutical industry.

Centered around the conference theme, "From Science to Systems to Patients," the conversation explores how innovation moves beyond discovery and development to become safe, reliable, and accessible therapies for patients. The guests explain how the conference agenda was designed to address the full pharmaceutical product lifecycle, from scientific breakthroughs and manufacturing systems to digital transformation, workforce development, governance, and supply chain performance.

Listeners will gain insight into the event's five interconnected educational tracks, which examine how organizations can balance innovation with accountability while navigating an increasingly complex pharmaceutical landscape. Key topics include artificial intelligence (AI), advanced analytics, data integrity, quality culture, workforce upskilling, risk management, inspection readiness, governance, and patient-centric operations.

The episode also highlights the importance of cross-functional collaboration among professionals in science, engineering, quality, operations, regulatory affairs, supply chain management, and technology. Throughout the discussion, the guests emphasize that successful innovation requires more than new technologies. It depends on trusted data, strong governance, capable people, and a shared commitment to improving patient outcomes.

Whether you are planning to attend the 2026 ISPE Annual Meeting & Expo or simply want to better understand the trends driving pharmaceutical manufacturing and operations, this episode offers valuable insight into the conversations shaping the industry's future.

Listen to this episode to learn:

  • The meaning behind the 2026 ISPE Annual Meeting & Expo theme, “From Science to Systems to Patients”
  • How the conference's five interconnected educational tracks address today's most important pharmaceutical industry challenges
  • Why artificial intelligence (AI), advanced analytics, and digital transformation continue to reshape pharmaceutical operations
  • How organizations can leverage AI while maintaining governance, oversight, and human accountability
  • Why data integrity and trusted decision-making are foundational to digital transformation success
  • The role of workforce development, digital literacy, and upskilling in an increasingly technology-enabled industry
  • How leading organizations are strengthening governance, risk management, and inspection readiness programs
  • Why quality culture, quality risk management, and proactive compliance remain critical priorities
  • The value of cross-functional collaboration among manufacturing, quality, regulatory, engineering, and technology professionals
  • How patient-centric thinking connects innovation, operations, and business decision-making across the pharmaceutical lifecycle

Who Should Listen?

This episode is ideal for:

  • Pharmaceutical manufacturing professionals
  • Quality assurance and quality systems leaders
  • Regulatory affairs professionals
  • Digital transformation and information technology teams
  • Data, analytics, and artificial intelligence leaders
  • Engineering and technical operations professionals
  • Supply chain and operational excellence teams
  • Pharmaceutical executives and business leaders
  • Workforce development and training professionals
  • Anyone planning to attend the 2026 ISPE Annual Meeting & Expo

Frequently Asked Questions

What is the theme of the 2026 ISPE Annual Meeting & Expo?

The 2026 conference theme is “From Science to Systems to Patients.” The theme reflects the complete journey of pharmaceutical innovation, from scientific discovery and process development to manufacturing, supply chain execution, and patient access.

What are the five educational tracks featured at the 2026 ISPE Annual Meeting & Expo?

The conference is organized around five interconnected tracks: Breakthrough to Bedside; Systems That Deliver Reliability; Digital, Data, and Decision Integrity; People, Capability, and the Workforce of Delivery; and Governance, Risk, and Readiness.

How is AI influencing pharmaceutical operations?

AI is helping organizations improve efficiency, enhance decision-making, analyze complex data sets, and support digital transformation initiatives. However, successful implementation also requires workforce training, governance frameworks, trusted data, and appropriate human oversight.

Why is workforce development a major focus for the pharmaceutical industry?

As advanced technologies become more widely adopted, organizations must help employees develop digital literacy, data fluency, critical-thinking skills, and the ability to work effectively alongside emerging technologies such as AI and advanced analytics.

Why are governance and risk management important in pharmaceutical manufacturing?

Strong governance helps organizations manage operational complexity, support compliance, maintain inspection readiness, and ensure that quality, safety, and business objectives remain aligned as new technologies and processes are introduced.

What is the importance of data integrity in pharmaceutical operations?

Data integrity helps ensure that information used for decision-making is accurate, reliable, and trustworthy. As organizations adopt AI, analytics, and digital systems, maintaining high-quality data becomes increasingly important for quality, compliance, and operational performance.

Why is cross-functional collaboration important for pharmaceutical innovation?

Successful pharmaceutical innovation requires collaboration across scientific, engineering, quality, manufacturing, regulatory, supply chain, and technology disciplines. Bringing together diverse perspectives can accelerate problem-solving, improve decision-making, and help organizations translate innovation into patient benefit.

Download Transcript 

Listen Anywhere


Featured Guests

Jose Caraballo-Oramas
Founder and Principal
JCO Global Advisory LLC
Connie Langer
Regulatory Intelligence Lead - Pharma Quality, Safety & Environmental Operations
Pfizer Global Supply

Listen to Past Episodes